Pseudoimmunofluorescent immunohistochemistry image analysis of phosphorylated signaling proteins in human esophageal squamous cell carcinoma tissue

被引:1
|
作者
Nishio, Mari [1 ]
Tsukamoto, Shuichi [1 ]
Kodama, Takayuki [1 ]
Shigeoka, Manabu [1 ]
Koma, Yu-ichiro [1 ]
Yokozaki, Hiroshi [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Pathol, Div Pathol, 7-5-1 Kusunoki Cho,Chuo Ku, Kobe 6500017, Japan
基金
日本学术振兴会;
关键词
esophageal cancer; image analysis; image conversion; immunohistochemistry; phosphorylated signaling proteins; pseudocolorization; pseudoimmunofluorescent images; MACROPHAGES;
D O I
10.1111/pin.13407
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemistry is primarily employed to visualize the localization of specific molecules in tissue samples. However, there is an increasing need for software-assisted quantitative assessment. In the present study, we performed inverted blue channel-based pseudoimmunofluorescence image analysis using original immunohistochemistry images. In human esophageal squamous cell carcinoma tissues, various humoral factors promote the phosphorylation of signaling proteins, including protein kinase B (Akt) and/or extracellular signal-regulated kinase 1/2 (ERK1/2), leading to tumor progression. Our method demonstrated applicability in the analysis of localized signaling proteins in histological sections. Relatively high phosphorylated Akt (p-Akt) intensity was observed in the cancer-stroma adjacent (Adj) and noncancerous regions of the superficial layer (SL). Furthermore, localized phosphorylated ERK1/2 (Thr202/Tyr204) was observed in the Adj of the SL and invasive front, distinct from the pattern of p-Akt (Ser473) and p-Akt (Thr308). In conclusion, pseudoimmunofluorescent immunohistochemistry image analysis is useful for the quantitative assessment and objective interpretation of localized signaling proteins in esophageal squamous cell carcinoma. The method can also be applied to analyze various immunohistochemistry images from diverse tissues.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [21] Pathway analysis of differentially expressed genes in human esophageal squamous cell carcinoma
    Xu, C. -Q.
    Zhu, S. -T.
    Wang, M.
    Guo, S. -L.
    Sun, X. -J.
    Cheng, R.
    Xing, J.
    Wang, W. -H.
    Shao, L. -L.
    Zhang, S. -T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (09) : 1652 - 1661
  • [22] Carvacrol Induces Cell Apoptosis in Human Esophageal Squamous Carcinoma the Human Esophageal Squamous Carcinoma Cell Line (KYSE-150) Cells
    Lin, DaoBin
    Yang, Zhangkai
    Su, YiHua
    Cheng, YaWei
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (09) : 1844 - 1847
  • [23] Immunohistochemistry analysis of WNT pathway in oral squamous cell carcinoma
    Eliza Cavicchioli, Buim M.
    Vanessa, Lourenco S.
    Candido, Carvalho K.
    Soares, A. F.
    VIRCHOWS ARCHIV, 2009, 455 : 324 - 324
  • [24] Phosphorylated mTOR Expression is Associated with Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma
    Hirashima, Kotaro
    Baba, Yoshifumi
    Watanabe, Masayuki
    Karashima, Ryu-ichi
    Sato, Nobutaka
    Imamura, Yu
    Hiyoshi, Yukiharu
    Nagai, Yohei
    Hayashi, Naoko
    Iyama, Ken-ichi
    Baba, Hideo
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) : 2486 - 2493
  • [25] Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
    Zhu, Zhengfei
    Yu, Weiwei
    Fu, Xiaolong
    Sun, Menghong
    Wei, Qiao
    Li, Dali
    Chen, Haiquan
    Xiang, Jiaqing
    Li, Hecheng
    Zhang, Yawei
    Zhao, Weixin
    Zhao, Kuaile
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [26] Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
    Zhengfei Zhu
    Weiwei Yu
    Xiaolong Fu
    Menghong Sun
    Qiao Wei
    Dali Li
    Haiquan Chen
    Jiaqing Xiang
    Hecheng Li
    Yawei Zhang
    Weixin Zhao
    Kuaile Zhao
    Journal of Experimental & Clinical Cancer Research, 34
  • [27] Phosphorylated mTOR Expression is Associated with Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma
    Kotaro Hirashima
    Yoshifumi Baba
    Masayuki Watanabe
    Ryu-ichi Karashima
    Nobutaka Sato
    Yu Imamura
    Yukiharu Hiyoshi
    Yohei Nagai
    Naoko Hayashi
    Ken-ichi Iyama
    Hideo Baba
    Annals of Surgical Oncology, 2010, 17 : 2486 - 2493
  • [28] Comparative proteomic analysis of esophageal squamous cell carcinoma
    Qi, YJ
    Chiu, JF
    Wang, LD
    Kwong, DLW
    He, QY
    PROTEOMICS, 2005, 5 (11) : 2960 - 2971
  • [29] Comprehensive analysis of methylation in esophageal squamous cell carcinoma
    Kidogami, Shinya
    Yamasaki, Makoto
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Mimori, Kohshi
    Mori, Masaki
    Doki, Yuuichirou
    CANCER SCIENCE, 2018, 109 : 237 - 237
  • [30] An analysis on the usefulness of ALDH in esophageal squamous cell carcinoma
    Murakami, Kentaro
    CANCER RESEARCH, 2015, 75